NCT04929028
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04929028
Title Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Zuckerberg San Francisco General Hospital San Francisco California 94110 United States Details
George Washington University Medical Center Washington D.C. District of Columbia 20037 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Illinois Chicago Illinois 60612 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Mount Sinai West New York New York 10019 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Mount Sinai Hospital New York New York 10029 United States Details
Montefiore Medical Center-Einstein Campus The Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus The Bronx New York 10467 United States Details
Pennsylvania Hospital Philadelphia Pennsylvania 19107 United States Details
Lyndon Baines Johnson General Hospital Houston Texas 77026-1967 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Mason Medical Center Seattle Washington 98101 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field